The postoperative effect of sevoflurane inhalational anesthesia on cognitive function and inflammatory response of

C-H Fan1, B Peng, F-C Zhang

  • 1Department of Anesthesiology, Xuzhou Children's Hospital, Xuzhou, Jiangsu, P.R. China. fanconghai020@163.com.

Insights

Prolonged sevoflurane anesthesia in children increases the risk of postoperative cognitive dysfunction (POCD). Higher levels of caspase-3, TNF-α, and IL-6 are linked to POCD after longer anesthesia durations.

Area of Science:

  • Pediatric Anesthesiology
  • Neuroinflammation
  • Cognitive Science

Background:

  • General anesthesia is essential for pediatric surgery.
  • Postoperative cognitive dysfunction (POCD) is a concern in children.
  • Sevoflurane is a common anesthetic agent.

Purpose of the Study:

  • To examine sevoflurane's impact on pediatric cognitive function.
  • To assess the inflammatory response in children post-anesthesia.
  • To correlate anesthesia duration with cognitive and inflammatory changes.

Main Methods:

  • Ninety-three pediatric patients were grouped by anesthesia duration (<1h, 1-3h, ≥3h).
  • Cognitive function and serum inflammatory markers (caspase-3, TNF-α, IL-6) were evaluated.
  • Comparisons were made between groups and POCD/non-POCD subgroups.

Main Results:

  • POCD occurred more frequently in children with anesthesia ≥3 hours (Group C).
  • Elevated caspase-3, TNF-α, and IL-6 levels were observed in the POCD group.
  • Inflammatory markers peaked during the recovery period in POCD patients.

Conclusions:

  • Extended sevoflurane anesthesia (≥3 hours) increases POCD risk in children.
  • Serum caspase-3, TNF-α, and IL-6 levels are associated with prolonged anesthesia and POCD.
  • Anesthesia duration is a critical factor influencing pediatric postoperative outcomes.
Abstract

Related Concept Videos

Inflammatory Response01:28

Inflammatory Response

An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
16.9K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
266
Inflammatory Response II: Inflammatory Exudate and Tissue Repair01:24

Inflammatory Response II: Inflammatory Exudate and Tissue Repair

The immune system's inflammatory response destroys the invading pathogen, permitting the tissue to heal. The changes during the cellular and vascular stages allow exudate formation at the site of inflammation. The inflammatory exudate released from the wound has high protein content and a specific gravity above 1.020.
The typical wound exudate is odorless, transparent, straw-colored, thin, and watery. Exudate, however, can differ depending on the state of wound healing. Likewise, the...
8.0K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
320
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
239
Inflammatory Response I: Vascular and Cellular01:30

Inflammatory Response I: Vascular and Cellular

The inflammatory response is the body's defense against infection, injury, or irritation from bacteria, trauma, toxins, or heat. Inflammation helps locate and destroy pathogens and remove damaged tissue elements to heal the body. During this initial phase, fluid, blood products, and nutrients migrate to the injured area, resulting in redness, heat, swelling, ache, and loss of function. Moreover, signs of systemic inflammation include fever, increased WBC count, malaise, anorexia, nausea,...
16.7K